HRP20140922T1 - Postupak dobivanja nebivolola - Google Patents
Postupak dobivanja nebivolola Download PDFInfo
- Publication number
- HRP20140922T1 HRP20140922T1 HRP20140922AT HRP20140922T HRP20140922T1 HR P20140922 T1 HRP20140922 T1 HR P20140922T1 HR P20140922A T HRP20140922A T HR P20140922AT HR P20140922 T HRP20140922 T HR P20140922T HR P20140922 T1 HRP20140922 T1 HR P20140922T1
- Authority
- HR
- Croatia
- Prior art keywords
- formula
- compound
- halogenmethyllithium
- derivative
- image
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 20
- KOHIRBRYDXPAMZ-YHBROIRLSA-N (S,R,R,R)-nebivolol Chemical compound C1CC2=CC(F)=CC=C2O[C@H]1[C@H](O)CNC[C@@H](O)[C@H]1OC2=CC=C(F)C=C2CC1 KOHIRBRYDXPAMZ-YHBROIRLSA-N 0.000 title claims 3
- 229960000619 nebivolol Drugs 0.000 title claims 3
- 150000001875 compounds Chemical class 0.000 claims 18
- 238000006243 chemical reaction Methods 0.000 claims 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 4
- 239000003153 chemical reaction reagent Substances 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 125000001979 organolithium group Chemical group 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical group [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims 2
- JPOXNPPZZKNXOV-UHFFFAOYSA-N bromochloromethane Chemical group ClCBr JPOXNPPZZKNXOV-UHFFFAOYSA-N 0.000 claims 2
- 239000011541 reaction mixture Substances 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- 239000004593 Epoxy Substances 0.000 claims 1
- VQEVKEKJZVEGPH-UHFFFAOYSA-N lithium;chloromethane Chemical group [Li+].Cl[CH2-] VQEVKEKJZVEGPH-UHFFFAOYSA-N 0.000 claims 1
- 238000007363 ring formation reaction Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Claims (16)
1. Postupak dobivanja spoja formule
[image]
,
gdje je X atom halogena,
naznačen time što se sastoji u reakciji spoja formule
[image]
,
gdje je R (C1-C6)-alkilna skupina,
s derivatom halogenmetillitija formule Li-CH2-X, u kojoj je X definiran kao gore.
2. Postupak u skladu s patentnim zahtjevom 1, naznačen time što se derivat halogenmetillitija dobiva u reakcijskom sustavu.
3. Postupak u skladu s patentnim zahtjevom 2, naznačen time što se derivat halogenmetillitija dobiva dodavanjem organolitijskog reagensa dihalogenmetanu.
4. Postupak u skladu s patentnim zahtjevom 3, naznačen time što je dihalogenmetan bromklormetan.
5. Postupak u skladu s patentnim zahtjevom 3 ili zahtjevom 4, naznačen time što je organolitijski reagens n-butillitij.
6. Postupak u skladu s bilo kojim od patentnih zahtjeva 3 do 5, naznačen time što se spoj formule (VI), dihalogenmetan i organolitijski reagens upotrebljava u molarnom omjeru od otprilike 1:2:2.
7. Postupak u skladu s bilo kojim od prethodnih zahtjeva, naznačen time što je derivat halogenmetillitija klormetillitij.
8. Postupak u skladu s bilo kojim od prethodnih zahtjeva, naznačen time što se reakciju spoja formule VI s derivatom halogenmetillitija provodi u prisutnosti otapala.
9. Postupak u skladu s patentnim zahtjevom 8, naznačen time što je otapalo tetrahidrofuran (THF).
10. Postupak u skladu s patentnim zahtjevom 1, naznačen time što se dodavanje halogenmetillitija spoju formule (VI) provodi u rasponu temperatura od –100 °C do 0 °C.
11. Postupak u skladu s patentnim zahtjevom 10, naznačen time što se dodavanje halogenmetillitija provodi u rasponu temperatura od –85 °C do –50 °C.
12. Postupak dobivanja spoja formule
[image]
,
naznačen time što se sastoji u prevođenju spoja formule (VI) u spoj formule (I) postupkom u skladu s patentnim zahtjevom 1.
13. Postupak u skladu s patentnim zahtjevom 12, naznačen time što se dodatno sastoji u
reduciranju spoja formule I kako bi se dobilo spoj formule (VIII):
[image]
,
u kojoj je X atom halogena, i
reakciji navedenog spoja formule (VIII) s bazom kako bi se dobilo epoksidni spoj formule (VII).
14. Postupak dobivanja spoja formule
[image]
,
naznačen time što se sastoji u reakciji spoja formule
[image]
,
u kojoj je R (C1-C6)-alkilna skupina, s derivatom halogenmetillitija formule Li-CH2-X, u kojoj je X atom halogena, kako bi se dobilo reakcijsku smjesu;
reduciranju navedene reakcijske smjese na licu mjesta; i
cikliziranju u prisutnosti baze.
15. Postupak dobivanja nebivolola, naznačen time što se sastoji u prevođenju spoja formule (VI) u spoj formule (I) postupkom u skladu s patentnim zahtjevom 1.
16. Postupak dobivanja nebivolola, naznačen time što se sastoji u prevođenju u jednoj posudi spoja formule (VI) u spoj formule (VII) postupkom u skladu s patentnim zahtjevom 14.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0856415 | 2008-09-24 | ||
PCT/FR2009/051775 WO2010034927A1 (fr) | 2008-09-24 | 2009-09-22 | Procede de preparation de nebivolol |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20140922T1 true HRP20140922T1 (hr) | 2014-11-07 |
Family
ID=40527387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20140922AT HRP20140922T1 (hr) | 2008-09-24 | 2014-09-26 | Postupak dobivanja nebivolola |
Country Status (12)
Country | Link |
---|---|
US (1) | US8981127B2 (hr) |
EP (1) | EP2328883B1 (hr) |
JP (1) | JP5744738B2 (hr) |
CN (1) | CN102164906A (hr) |
AU (1) | AU2009295730B2 (hr) |
BR (1) | BRPI0919257B8 (hr) |
CA (1) | CA2736600C (hr) |
ES (1) | ES2523343T3 (hr) |
HR (1) | HRP20140922T1 (hr) |
IL (1) | IL211410A (hr) |
PL (1) | PL2328883T3 (hr) |
WO (1) | WO2010034927A1 (hr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102180855B (zh) * | 2011-03-01 | 2015-11-25 | 浙江华海药业股份有限公司 | 一种奈必洛尔中间体的提纯方法 |
ITRM20110418A1 (it) | 2011-08-02 | 2013-02-03 | Menarini Int Operations Lu Sa | Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo. |
PT2907809T (pt) | 2014-02-14 | 2019-01-16 | Corden Pharma Int Gmbh | Processo sem base para a preparação de intermediários de cetona utilizáveis para fabrico de nebivolol |
CN104610215A (zh) * | 2015-01-19 | 2015-05-13 | 浙江海翔药业股份有限公司 | 一种奈必洛尔中间体的制备方法及奈必洛尔的制备方法 |
ITUB20160227A1 (it) * | 2016-01-21 | 2017-07-21 | Menarini Int Operations Luxembourg Sa | Processo per la sintesi di intermedi di Nebivololo |
CN108997297B (zh) * | 2018-07-17 | 2020-12-01 | 浙江海翔药业股份有限公司 | 一种奈必洛尔中间体的制备方法、用于制备该奈必洛尔中间体的中间体及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591885A (en) | 1994-09-23 | 1997-01-07 | Hoffman-La Roche Inc. | Process for the preparation of halogenated α-aminoketone compounds |
US5523463A (en) * | 1994-09-23 | 1996-06-04 | Hoffmann-La Roche Inc. | Method of producing halogenated and alpha-aminoalchohols |
US6127556A (en) * | 1996-12-31 | 2000-10-03 | G. D. Searle & Co. | Epoxide formation by continuous in-situ synthesis process |
EP1534683A4 (en) * | 2002-06-27 | 2005-08-24 | Nitromed Inc | CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHOD OF USE |
EP1937649A1 (en) * | 2005-10-14 | 2008-07-02 | Neurosearch A/S | Imidazole derivatives for the treatment of anxiety and related diseases |
US7560575B2 (en) * | 2005-12-28 | 2009-07-14 | Acino Pharma Ag | Process for preparation of racemic Nebivolol |
ITMI20061889A1 (it) * | 2006-10-03 | 2008-04-04 | Zambon Spa | Processo di preparazione di nebivololo |
EP2061759B1 (en) * | 2006-10-04 | 2013-03-27 | Bristol-Myers Squibb Company | Cyclic modulators of chemokine receptor activity |
NZ582249A (en) * | 2007-06-28 | 2012-06-29 | Intervet Int Bv | Substituted piperazines as cb1 antagonists |
-
2009
- 2009-09-22 CA CA2736600A patent/CA2736600C/fr active Active
- 2009-09-22 CN CN2009801373139A patent/CN102164906A/zh active Pending
- 2009-09-22 WO PCT/FR2009/051775 patent/WO2010034927A1/fr active Application Filing
- 2009-09-22 JP JP2011528395A patent/JP5744738B2/ja active Active
- 2009-09-22 US US13/120,690 patent/US8981127B2/en active Active
- 2009-09-22 BR BRPI0919257A patent/BRPI0919257B8/pt active IP Right Grant
- 2009-09-22 ES ES09747893.7T patent/ES2523343T3/es active Active
- 2009-09-22 PL PL09747893T patent/PL2328883T3/pl unknown
- 2009-09-22 EP EP09747893.7A patent/EP2328883B1/fr active Active
- 2009-09-22 AU AU2009295730A patent/AU2009295730B2/en active Active
-
2011
- 2011-02-24 IL IL211410A patent/IL211410A/en active IP Right Grant
-
2014
- 2014-09-26 HR HRP20140922AT patent/HRP20140922T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2009295730A1 (en) | 2010-04-01 |
WO2010034927A1 (fr) | 2010-04-01 |
EP2328883B1 (fr) | 2014-08-06 |
AU2009295730B2 (en) | 2013-12-19 |
PL2328883T3 (pl) | 2015-01-30 |
CN102164906A (zh) | 2011-08-24 |
BRPI0919257A2 (pt) | 2015-08-18 |
EP2328883A1 (fr) | 2011-06-08 |
IL211410A (en) | 2015-10-29 |
BRPI0919257B1 (pt) | 2021-05-04 |
CA2736600C (fr) | 2017-03-21 |
IL211410A0 (en) | 2011-05-31 |
US8981127B2 (en) | 2015-03-17 |
CA2736600A1 (fr) | 2010-04-01 |
JP5744738B2 (ja) | 2015-07-08 |
BRPI0919257B8 (pt) | 2021-05-25 |
JP2012503636A (ja) | 2012-02-09 |
ES2523343T3 (es) | 2014-11-25 |
US20110237808A1 (en) | 2011-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20140922T1 (hr) | Postupak dobivanja nebivolola | |
CA2510093A1 (en) | Novel process for the preparation of.alpha.-chlorovinyl, .alpha.,.alpha.-dichloro, and acetylenes from ketones | |
MY198064A (en) | Method for preparing 3-trifluoromethyl chalcones | |
PE20060649A1 (es) | Forma polimorfa ii de rapamicina y proceso de preparacion | |
NO20092960L (no) | Krystallinsk minocycline base og framgangsmater for framstilling av denne | |
Imai et al. | First catalytic and enantioselective synthesis of silyl and stannyl substituted cyclopropylmethanols | |
Xie et al. | Efficient and mild synthesis of functionalized 2, 3-dihydrofuran derivatives via domino reaction in water | |
CN104520275B (zh) | 用于制备整合酶抑制剂的方法和中间产物 | |
HRP20110418T1 (hr) | Kristalizacija čvrstih oblika adicijskih soli klopidogrela | |
EP2178871A2 (en) | Cyclic ethers | |
CN105175299A (zh) | 使用二氧化硒制备2,2’-二芳基硒醚或者4,4’-二芳基硒醚的方法 | |
JP2011519860A5 (hr) | ||
HRP20160740T1 (hr) | Postupak pripreme nebivolola | |
Liang et al. | Catalytic asymmetric brominative dearomatization reaction of benzofurans | |
JP2016535033A (ja) | 活性化されていない第二級ボロン酸のクロスカップリング | |
CN112940036B (zh) | 一种苯并噻唑磷酸酯化合物的制备方法 | |
Suzuki et al. | Formal synthesis of (+)-isolaurepinnacin | |
WO2010011546A3 (en) | Pyrrolo [3, 2-b]pyridines and pyrazolo [4, 3 -b] pyridines having 5-ht6 receptor affinity | |
Pandey et al. | Imino-ene reaction of N-tosyl arylaldimines with α-methylstyrene: application in the synthesis of important amines | |
EP2816044A1 (en) | Intermediate for acenedichalcogenophene derivative and method for synthesizing same | |
Mandai et al. | Bacteriogenic iron oxide as an effective catalyst for Baeyer-Villiger oxidation with molecular oxygen and benzaldehyde | |
CN106928165A (zh) | 一种四氢糠基醚类化合物的制备方法 | |
WO2007077485A3 (en) | Method for producing metallocenes | |
HRP20141087T1 (hr) | Sintetički međuproizvod spoja oksazola i postupak za njegovu proizvodnju | |
WO2009079578A8 (en) | Low voc waterbased coatings with efflorescence resistance |